186 related articles for article (PubMed ID: 30723247)
21. Intravenous leiomyomatosis of the uterus.
Arora R; Abou-Bakr AA; Ahmad MS
Gulf J Oncolog; 2010 Jan; (7):57-9. PubMed ID: 20164011
[TBL] [Abstract][Full Text] [Related]
22. Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.
Canzonieri V; D'Amore ES; Bartoloni G; Piazza M; Blandamura S; Carbone A
Virchows Arch; 1994; 425(5):541-5. PubMed ID: 7850080
[TBL] [Abstract][Full Text] [Related]
23. Vanishing intravenous leiomyomatosis after hysterectomy: Assessment of the need to perform complete resection.
Maneyama H; Miyasaka N; Wakana K; Nakamura M; Kitazume Y; Kubota T
J Obstet Gynaecol Res; 2016 Aug; 42(8):1058-62. PubMed ID: 27080990
[TBL] [Abstract][Full Text] [Related]
24. The value of (18)F-FDG PET/CT in the diagnosis of uterine intravenous leiomyomatosis extended into the right atrium.
Xiao J; Liu G; Cheng D; Wang H; Shi H
Hell J Nucl Med; 2016; 19(2):179-81. PubMed ID: 27331217
[TBL] [Abstract][Full Text] [Related]
25. Myomectomy for intravenous leiomyomatosis: a retrospective series of 9 cases.
Lu ZY; Zhang N; Zhang Y
J Obstet Gynaecol; 2022 May; 42(4):665-669. PubMed ID: 34396916
[TBL] [Abstract][Full Text] [Related]
26. Massive pelvic recurrence of uterine leiomyomatosis with intracaval-intracardiac extension: video case report and literature review.
Castagneto Gissey L; Mariano G; Musleh L; Lepiane P; Colasanti M; Meniconi RL; Ranocchi F; Musumeci F; Antonini M; Ettorre GM
BMC Surg; 2017 Nov; 17(1):118. PubMed ID: 29187188
[TBL] [Abstract][Full Text] [Related]
27. Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience.
Shi P; Xiao H; Li H; Tang W; Ren A; Ma L; Tu R; Yin S; Zhang J
Ann Transl Med; 2022 May; 10(9):503. PubMed ID: 35692495
[TBL] [Abstract][Full Text] [Related]
28. Intravenous leiomyomatosis treated with radical hysterectomy and adjuvant aromatase inhibitor therapy.
Mizoguchi C; Matsumoto H; Nasu K; Arakane M; Kai K; Narahara H
J Obstet Gynaecol Res; 2016 Oct; 42(10):1405-1408. PubMed ID: 27436168
[TBL] [Abstract][Full Text] [Related]
29. Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases.
Mulvany NJ; Slavin JL; Ostör AG; Fortune DW
Int J Gynecol Pathol; 1994 Jan; 13(1):1-9. PubMed ID: 8112951
[TBL] [Abstract][Full Text] [Related]
30. Anestheic Management of a Patient with Intravenous Leiomyomatosis Extending into the Right Atrium.
Kodama M; Honma M; Shibukawa K; Kamada Y; Yanagiya S; Yamakage M
Masui; 2017 May; 66(5):542-545. PubMed ID: 29693945
[TBL] [Abstract][Full Text] [Related]
31. Update on intravenous leiomyomatosis: report of five patients and literature review.
Valdés Devesa V; Conley CR; Stone WM; Collins JM; Magrina JF
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):209-13. PubMed ID: 24207051
[TBL] [Abstract][Full Text] [Related]
32. CD10 in diffuse uterine leiomyomatosis: a case report along with a few comments on histogenesis.
Jambhekar NA; Moonim MT; Chaturvedi A
Indian J Pathol Microbiol; 2006 Jul; 49(3):442-5. PubMed ID: 17001917
[TBL] [Abstract][Full Text] [Related]
33. Mechanical Signaling and Extracellular Matrix in Uterine Fibroids.
Rafique S; Segars JH; Leppert PC
Semin Reprod Med; 2017 Nov; 35(6):487-493. PubMed ID: 29100236
[No Abstract] [Full Text] [Related]
34. Identification of genomic copy number variations in lung benign metastasizing leiomyomatosis.
Hernández-Plata E; Velázquez-Wong AC; Jiménez-Ramírez C; Fernández-Ramírez F; Galicia-Sánchez LM; Flores-García CA; Hernández-Hernández JM; Rosas-Vargas H; Huicochea-Montiel JC; Espinosa-Poblano E
Clin Respir J; 2019 Feb; 13(2):105-113. PubMed ID: 30597752
[TBL] [Abstract][Full Text] [Related]
35. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
[TBL] [Abstract][Full Text] [Related]
36. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
37. Successful one-stage complete removal of an entire intravenous leiomyomatosis in the heart, vena cava, and uterus.
Arinami Y; Kodama S; Kase H; Tanaka K; Okazaki H; Maruyama Y
Gynecol Oncol; 1997 Mar; 64(3):547-50. PubMed ID: 9062168
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of LIF mRNA in patients withmyoma uteri.
Kara M; Sabah Ozcan S; Aran T; Kara O; Yilmaz N
J Cell Biochem; 2019 Mar; 120(3):3423-3427. PubMed ID: 30242886
[TBL] [Abstract][Full Text] [Related]
39. Uptake and phosphorylation of 2-deoxy-D-glucose by normal human uterine muscles and uterine myomata.
Goldberg E; Rosenblum I
Experientia; 1968 Jul; 24(7):700. PubMed ID: 5705238
[No Abstract] [Full Text] [Related]
40. Two Case Reports of Intravenous Leiomyomatosis with Hyaluronan Expression.
Konishi H; Koh I; Shiroma N; Kidani Y; Urabe S; Tanaka N; Hirata E; Arihiro K; Kudo Y
Case Rep Obstet Gynecol; 2018; 2018():4039183. PubMed ID: 30112233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
